Profile data is unavailable for this security.
About the company
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
- Revenue in USD (TTM)2.29bn
- Net income in USD1.74bn
- Incorporated1997
- Employees14.53k
- LocationAlign Technology Inc2820 Orchard PkwySAN JOSE 95134-2019United StatesUSA
- Phone+1 (408) 470-1000
- Fax+1 (408) 470-1010
- Websitehttp://www.aligntech.com/
More ▼
Mergers & acquisitions
| Acquired company | ALGN:NSQ since announced | Transaction value |
|---|---|---|
| exocad GmbH | 89.74% | 420.03m |
Data delayed at least 15 minutes, as of Oct 30 2020 20:15 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cooper Companies Inc | 2.44bn | 272.40m | 18.57bn | 12.00k | 59.24 | 4.23 | 31.27 | 7.08 | 5.47 | 5.59 | 49.11 | 76.58 | 0.3778 | 1.60 | 5.71 | 203,408.30 | 4.22 | 6.60 | 5.00 | 7.44 | 64.15 | 63.11 | 11.16 | 15.05 | 0.6436 | 7.26 | 0.3334 | 0.8777 | 4.76 | 9.09 | 30.01 | 11.30 | 4.18 | 0.00 |
| West Pharmaceutical Services Inc. | 2.04bn | 311.70m | 20.71bn | 8.20k | 66.77 | 11.83 | 50.63 | 9.99 | 4.12 | 4.12 | 26.94 | 23.26 | 0.8566 | 5.05 | 5.91 | 248,451.20 | 12.40 | 9.48 | 14.85 | 11.20 | 34.85 | 32.49 | 14.48 | 10.89 | 2.11 | -- | 0.1295 | 21.64 | 7.13 | 5.30 | 18.25 | 13.72 | 2.43 | 8.27 |
| ResMed Inc. | 2.96bn | 621.67m | 26.16bn | 7.77k | 42.06 | 10.42 | 33.50 | 8.80 | 4.27 | 4.27 | 20.31 | 17.23 | 0.6802 | 3.20 | 5.78 | 380,567.80 | 14.30 | 12.62 | 16.50 | 14.75 | 58.55 | 57.71 | 21.02 | 18.46 | 1.84 | 12.82 | 0.3202 | 45.44 | 13.44 | 11.99 | 51.41 | 11.99 | 8.05 | 6.85 |
| Zimmer Biomet Holdings Inc | 7.03bn | 36.70m | 28.89bn | 19.90k | 817.69 | 2.38 | 26.39 | 3.94 | 0.1637 | 0.1637 | 33.94 | 56.27 | 0.2937 | 0.8539 | 6.08 | 353,165.80 | 0.1509 | 1.45 | 0.1719 | 1.60 | 70.59 | 70.72 | 0.5137 | 4.69 | 1.02 | 8.48 | 0.4135 | 53.74 | 0.6215 | 11.30 | 405.10 | 9.46 | 16.05 | 1.76 |
| Align Technology, Inc. | 2.29bn | 1.74bn | 35.81bn | 14.53k | 19.86 | 11.34 | 20.66 | 15.04 | 21.99 | 21.99 | 28.94 | 38.50 | 0.6761 | 6.08 | 3.95 | 157,412.80 | 51.38 | 18.60 | 72.82 | 26.41 | 71.04 | 74.16 | 75.99 | 19.47 | 1.20 | -- | -- | 0.00 | 22.39 | 25.87 | 10.63 | 24.87 | 44.10 | -- |
| DexCom, Inc. | 1.82bn | 231.10m | 40.02bn | 3.90k | 138.81 | 21.47 | 110.23 | 17.68 | 2.42 | 2.42 | 19.00 | 15.62 | 0.605 | 3.82 | 6.02 | 466,820.50 | 7.68 | -1.96 | 8.91 | -2.31 | 66.32 | 65.65 | 12.69 | -2.24 | 6.00 | 5.92 | 0.5313 | -- | 43.08 | 41.61 | 179.29 | -- | 61.86 | -- |
| Baxter International Inc | 11.53bn | 733.00m | 40.50bn | 50.00k | 55.40 | 4.66 | 25.32 | 3.43 | 1.41 | 1.76 | 22.42 | 16.77 | 0.6167 | 3.67 | 6.05 | 230,620.00 | 3.97 | 9.52 | 4.74 | 11.99 | 41.12 | 42.29 | 6.43 | 16.39 | 2.06 | 13.44 | 0.4299 | 24.49 | 2.37 | 1.17 | -40.00 | 12.04 | -18.18 | -16.14 |
| Edwards Lifesciences Corp | 4.37bn | 796.90m | 48.55bn | 13.90k | 58.24 | 10.79 | 50.75 | 10.40 | 1.25 | 1.25 | 6.92 | 6.76 | 0.6844 | 1.55 | 7.80 | 314,295.00 | 12.48 | 15.19 | 14.30 | 18.11 | 75.50 | 74.39 | 18.24 | 21.99 | 2.61 | -- | 0.1238 | 0.00 | 16.79 | 13.36 | 42.24 | 5.29 | 24.33 | -- |
| Boston Scientific Corporation | 10.11bn | -417.00m | 52.73bn | 36.00k | -- | -- | 76.93 | 4.74 | -0.2938 | 2.61 | 7.13 | -- | -- | -- | -- | 280,805.60 | -- | 3.27 | -- | 4.13 | 67.15 | 70.79 | -3.95 | 7.20 | -- | 2.91 | -- | 0.00 | 9.28 | 7.78 | -62.72 | -- | 16.44 | -- |
Data as of Oct 30 2020. Currency figures normalised to Align Technology Inc's reporting currency: US Dollar USD
42.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2020 | 7.67m | 9.74% |
| Edgewood Management LLCas of 30 Jun 2020 | 5.14m | 6.52% |
| BlackRock Fund Advisorsas of 30 Jun 2020 | 4.03m | 5.12% |
| Polen Capital Management LLCas of 30 Jun 2020 | 3.26m | 4.14% |
| Sands Capital Management LLCas of 30 Jun 2020 | 3.15m | 3.99% |
| SSgA Funds Management, Inc.as of 30 Jun 2020 | 3.11m | 3.94% |
| Renaissance Technologies LLCas of 30 Jun 2020 | 2.21m | 2.81% |
| AllianceBernstein LPas of 30 Jun 2020 | 1.97m | 2.50% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2020 | 1.44m | 1.83% |
| Bares Capital Management, Inc.as of 30 Jun 2020 | 1.40m | 1.78% |
More ▼
Data from 30 Jun 2020 - 30 Jun 2020Source: FactSet Research Systems Inc.
